Citation: Rw. Chesney, The impact of medical school loans and the promise of loan repayment on entry into a pediatric academic career, ARCH PED AD, 155(12), 2001, pp. 1296-1297
Authors:
Maung, HM
Elangovan, L
Frazao, JM
Bower, JD
Kelley, BJ
Acchiardo, SR
Rodriguez, HJ
Norris, KC
Sigala, JF
Rutkowski, M
Robertson, JA
Goodman, WG
Levine, BS
Chesney, RW
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Hm. Maung et al., Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison, AM J KIDNEY, 37(3), 2001, pp. 532-543
Citation: Rw. Chesney, Joseph W. St. Geme, Jr address 2001: Can one have a successful academic career in 2001?, PEDIATRICS, 108(6), 2001, pp. 1349-1352
Authors:
Chesney, RW
Adamson, P
Wells, T
Wilson, JT
Walson, PD
Citation: Rw. Chesney et al., The testing of antihypertensive medications in children: Report of the antihypertensive agent guidelines subcommittee of the Pediatric Pharmacology Research Units, PEDIATRICS, 107(3), 2001, pp. 558-561
Citation: Rw. Chesney, A practical approach to the evaluation of antihypertensive agents in infants and children: Study design and outcome measures, CURR THER R, 62(4), 2001, pp. 351-360
Authors:
Frazao, JM
Elangovan, L
Maung, HM
Chesney, RW
Acchiardo, SR
Bower, JD
Kelley, BJ
Rodriguez, HJ
Norris, KC
Robertson, JA
Levine, BS
Goodman, WG
Gentile, D
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Jm. Frazao et al., Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism, AM J KIDNEY, 36(3), 2000, pp. 550-561
Citation: Xb. Han et al., Ser-322 is a critical site for PKC regulation of the MDCK cell taurine transporter (pNCT), J AM S NEPH, 10(9), 1999, pp. 1874-1879
Citation: Rw. Chesney et M. Broyer, Urolithiasis in Tunisian children: a study of 120 cases based on stone composition - Commentary, PED NEPHROL, 13(9), 1999, pp. 926-926
Authors:
Kaste, SC
Chesney, RW
Hudson, MM
Lustig, RH
Rose, SR
Carbone, LD
Citation: Sc. Kaste et al., Bone mineral status during and after therapy of childhood cancer: An increasing population with multiple risk factors for impaired bone health, J BONE MIN, 14(12), 1999, pp. 2010-2014